Last reviewed · How we verify

NCT06653790

PSYCHOSOCIAL STIMULATIONS AND TREATMENT OUTCOME OF SEVERE ACUTE MALNOURISHED CHILDREN

Not yet recruiting NA Last updated 22 October 2024
What this trial tests

NA trial testing Psychosocial stimulations in Malnutrition Severe in 800 participants. Not yet recruiting.

Timeline
10 November 2024
Primary endpoint
15 March 2025
10 April 2025

Quick facts

Lead sponsorUniversiti Putra Malaysia
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposehealth services research
Enrollment800
Start date10 November 2024
Primary completion15 March 2025
Estimated completion10 April 2025

Drugs / interventions tested

Conditions studied

Sponsor

Universiti Putra Malaysia — full company profile →

Who can join

Adults 6 Months to 59 Months, any sex, with Malnutrition Severe. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A playroom and a playground are already part of the stabilization unit and are furnished with basic facilities for engaging the SAM children in play-based motor, language, and personal-social activities. The severely acute malnourished children in the intervention group will be sent to a development pediatrician who will do a developmental assessment of the child and stimulation. A sensory therapist, an occupational therapist, and a physiotherapist will also be available for sessions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Malnutrition Severe

Currently open trials in the same condition.

Other Universiti Putra Malaysia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06653790.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing